New antiviral treatment could significantly reduce global burden of hepatitis C University of Bristol Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer.1 New prevention strategies are urgently required as ... |
